Ophelia

Ophelia (legal name Ophelia Health Inc.) is a New York City-based digital health provider that delivers medication-assisted treatment (MAT) for opioid use disorder through telemedicine. Patients enroll online, meet a dedicated clinical care team over Zoom video visits, and, if eligible, receive a prescription for Suboxone (buprenorphine plus naloxone) or its generic equivalent sent to a local pharmacy. Beyond the core medication, clinicians can prescribe comfort medications for withdrawal symptoms such as nausea and insomnia and treat commonly co-occurring conditions including depression and anxiety [0][2][3].

The care model is built around removing the barriers associated with residential rehab: no travel, no mandatory groups or 12-step attendance, appointments available seven days a week, and an intake process the company says results in being seen within one to three days. Care teams combine clinicians, nurses, care coordinators, enrollment coordinators and peers; triage nurses provide round-the-clock clinical support. Visit cadence is weekly during the first month of stabilization, biweekly thereafter, and monthly after roughly three months [0][2][3].

Clinically, the company describes a digitally native model adapting the Massachusetts Collaborative Care Model to telemedicine, with synchronous video visits, FDA-approved medications, urine drug screens, on-demand messaging, optional groups, and care coordination. Ophelia was co-designed by addiction psychiatrists Dr. Arthur Robin Williams (Chief Medical Officer) and Dr. Adam Bisaga (Senior Medical Director), both academic researchers at Columbia University / New York State Psychiatric Institute [4][5].